126 related articles for article (PubMed ID: 3857180)
1. Optimal schedule for anthracyclines.
Smith IE
Eur J Cancer Clin Oncol; 1985 Feb; 21(2):159-61. PubMed ID: 3857180
[No Abstract] [Full Text] [Related]
2. Cardiotoxicity of anthracyclines.
Green MD; Speyer JL; Muggia FM
Eur J Cancer Clin Oncol; 1984 Feb; 20(2):293-6. PubMed ID: 6584310
[No Abstract] [Full Text] [Related]
3. Studies with anthracyclines in pediatric acute nonlymphocytic leukemia.
Chard RL
Cancer Treat Rep; 1981; 65 Suppl 4():77-81. PubMed ID: 6179617
[TBL] [Abstract][Full Text] [Related]
4. Impact of scheduling on toxicity and clinical efficacy of doxorubicin: what do we know in the mid-nineties?
Bielack SS; Erttmann R; Kempf-Bielack B; Winkler K
Eur J Cancer; 1996 Sep; 32A(10):1652-60. PubMed ID: 8983270
[No Abstract] [Full Text] [Related]
5. Anthracyclines in the treatment of acute nonlymphocytic leukemias.
Boiron M; Jacquillat C; Marty M; Weil M; Gisselbrecht C
Cancer Treat Rep; 1981; 65 Suppl 4():73-6. PubMed ID: 6955013
[No Abstract] [Full Text] [Related]
6. [Phase I study of SM-5887, a new anthracycline derivative].
Inoue K; Ogawa M; Horikoshi N; Mukaiyama T; Itoh Y; Imajoh K; Ozeki H; Nagamine D; Shinagawa K
Gan To Kagaku Ryoho; 1988 May; 15(5):1771-6. PubMed ID: 3369871
[TBL] [Abstract][Full Text] [Related]
7. Aclacinomycin A. Phase II evaluation in bronchogenic squamous-cell carcinoma.
Pazdur R; Samson MK; Baker LH
Am J Clin Oncol; 1987 Jun; 10(3):234-6. PubMed ID: 3473923
[TBL] [Abstract][Full Text] [Related]
8. Phase I-II trial of aclacinomycin A given in a four-consecutive-day schedule to patients with solid tumours. A South-East European Oncology Group (SEEOG) Study.
Kerpel-Fronius S; Gyergyay F; Hindy I; Decker A; Sawinsky I; Fäller K; Mechl Z; Nekulova M; Kolaric K; Tomek R
Oncology; 1987; 44(3):159-63. PubMed ID: 3474571
[TBL] [Abstract][Full Text] [Related]
9. [Optimal administration schedules of antineoplastic antibiotics based on their pharmacokinetics, with special reference to bleomycins and anthracyclines].
Ota K; Goto T; Fukushima M; Ariyoshi Y
Gan To Kagaku Ryoho; 1982 Aug; 9(8):1352-61. PubMed ID: 6191712
[TBL] [Abstract][Full Text] [Related]
10. The anthracycline antineoplastic drugs.
Young RC; Ozols RF; Myers CE
N Engl J Med; 1981 Jul; 305(3):139-53. PubMed ID: 7017406
[No Abstract] [Full Text] [Related]
11. [Scalp hypothermia as a preventive of alopecia in patients receiving combined chemotherapy including anthracyclines].
Perevodchikova NI; Denisov LE; Orel NF; Trofimova NB; Iarygin LM
Vopr Onkol; 1987; 33(10):73-5. PubMed ID: 3479861
[TBL] [Abstract][Full Text] [Related]
12. [Phase I and pharmacokinetic study of SM-5887 by 5-day schedule].
Inoue K; Matsumura A; Horikoshi N; Aiba K; Mukaiyama T; Matsumura T; Ogihara A; Sumida T; Ogawa M
Gan To Kagaku Ryoho; 1992 Apr; 19(4):477-82. PubMed ID: 1558397
[TBL] [Abstract][Full Text] [Related]
13. Clinical phase I study of aclacinomycin A by evaluation of an intermittent intravenous administration schedule.
Casper ES; Gralla RJ; Young CW
Cancer Res; 1981 Jun; 41(6):2417-20. PubMed ID: 6940656
[TBL] [Abstract][Full Text] [Related]
14. Biweekly Pegylated Liposomal Doxorubicin (Caelyx) in Heavily Pretreated Metastatic Breast Cancer: A Phase 2 Study.
Jehn CF; Hemmati P; Lehenbauer-Dehm S; Kümmel S; Flath B; Schmid P
Clin Breast Cancer; 2016 Dec; 16(6):514-519. PubMed ID: 27395417
[TBL] [Abstract][Full Text] [Related]
15. Heart failure in a breast cancer survivor.
Moore S
Oncol Nurs Forum; 2012 Mar; 39(2):147-50. PubMed ID: 22374488
[No Abstract] [Full Text] [Related]
16. Experimental and clinical studies on aclarubicin in the treatment of solid tumors.
Kumai K; Kubota T; Ishibiki K; Abe O
Biomed Pharmacother; 1984; 38(7):332-7. PubMed ID: 6596963
[TBL] [Abstract][Full Text] [Related]
17. [Preoperative intra-arterial chemotherapy with THP-ADR for locally advanced breast cancer].
Mukai S; Fujisaki T; Sato N
Gan To Kagaku Ryoho; 1995 Sep; 22(11):1542-5. PubMed ID: 7574754
[TBL] [Abstract][Full Text] [Related]
18. [Intravesical instillation therapy of aclacinomycin-A (ACM) for superficial bladder tumor].
Noguchi S; Kubota Y; Shuin T; Miura T; Moriyama M; Sakuramoto T; Oshima H
Hinyokika Kiyo; 1984 Sep; 30(9):1153-8. PubMed ID: 6596878
[TBL] [Abstract][Full Text] [Related]
19. Phase II study of weekly low-dose 4'-epi-doxorubicin in advanced postmenopausal breast cancer.
Jones WG; Mattsson W
Cancer Treat Rep; 1984 Apr; 68(4):675-7. PubMed ID: 6585271
[TBL] [Abstract][Full Text] [Related]
20. Reducing the cardiotoxicity of anthracyclines by complex-binding to DNA: report of three cases.
Paul C; Lönnqvist B; Gahrton G; Lockner D; Peterson C
Cancer; 1981 Oct; 48(7):1531-4. PubMed ID: 6945142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
